Market research
ABC AmerisourceBergen
NYSE USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 36B
- P/E ratio
- 21.92
- Analyst target
- 209.57
- Dividend yield
- 1.0%
- Beta
- 0.56
Profile
Company facts
- Exchange
- NYSE
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Distribution
- ISIN
- US03073E1055
- Market cap
- 36B
- P/E ratio
- 21.92
- Analyst target
- 209.57
- Dividend yield
- 1.0%
- Beta
- 0.56
About
About AmerisourceBergen
AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ABC discussion.
5 years, 4 months ago
AmerisourceBergen Corporation is currently in a long term uptrend where the price is trading 5.2% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.
AmerisourceBergen Corporation's total revenue rose by 9.7% to $53B since the same quarter in the previous year.
Its net income has increased by 99.8% to $375M since the same quarter in the previous year.
Finally, its free cash flow grew by 1009.4% to $838M since the same quarter in the previous year.
Based on the above factors, AmerisourceBergen Corporation gets an overall score of 5/5.